Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
- 24 May 2021
- journal article
- letter
- Published by Elsevier BV in Journal of Infection
- Vol. 83 (2), 237-279
- https://doi.org/10.1016/j.jinf.2021.05.018
Abstract
No abstract availableFunding Information
- Council of Scientific & Industrial Research
This publication has 10 references indexed in Scilit:
- Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- SARS-CoV-2 spike E484K mutation reduces antibody neutralisationThe Lancet Microbe, 2021
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workersJournal of Infection, 2021
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialThe Lancet, 2021
- SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escapeCell, 2021
- High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencingPLOS ONE, 2021
- Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralizationCell Host & Microbe, 2021
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trialThe Lancet Infectious Diseases, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020